HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M S Czuczman Selected Research

galiximab

11/2018Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness.
9/2012Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M S Czuczman Research Topics

Disease

11Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2015 - 09/2000
6Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2018 - 02/2005
6Neoplasms (Cancer)
07/2015 - 03/2001
5Lymphoma (Lymphomas)
07/2015 - 01/2001
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
08/2015 - 07/2011
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
08/2015 - 07/2011
2Hodgkin Disease (Hodgkin's Disease)
04/2008 - 03/2005
1Necrosis
12/2010
1Hematologic Neoplasms (Hematological Malignancy)
09/2010
1Acute Kidney Injury (Acute Renal Failure)
08/2003
1Bacteremia
07/2003
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
03/2001
1B-Cell Leukemia (Leukemia, B Cell)
01/2001

Drug/Important Bio-Agent (IBA)

9Rituximab (Mabthera)FDA Link
11/2018 - 09/2000
6Monoclonal AntibodiesIBA
11/2018 - 09/2000
3Lenalidomide (CC 5013)FDA Link
08/2015 - 07/2011
2galiximabIBA
11/2018 - 09/2012
2AntibodiesIBA
07/2015 - 09/2009
1Immunologic Factors (Immunomodulators)IBA
08/2015
1Immunoconjugates (Immunoconjugate)IBA
07/2015
1AntigensIBA
07/2015
1mapatumumabIBA
12/2010
1LigandsIBA
12/2010
1Proteasome InhibitorsIBA
09/2010
1Proteins (Proteins, Gene)FDA Link
09/2010
1Bortezomib (Velcade)FDA Link
09/2010
1Etoposide (VP 16)FDA LinkGeneric
04/2008
1Carmustine (FIVB)FDA Link
04/2008
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2008
1fludarabineIBA
02/2005
1Anti-Bacterial Agents (Antibiotics)IBA
03/2001
1Pharmaceutical PreparationsIBA
03/2001
1Antiviral Agents (Antivirals)IBA
03/2001
1Antifungal AgentsIBA
03/2001
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
03/2001
1Alemtuzumab (Campath)FDA Link
03/2001

Therapy/Procedure

5Therapeutics
08/2015 - 09/2000
3Drug Therapy (Chemotherapy)
08/2015 - 02/2005
3Transplantation
03/2005 - 03/2001
2Immunotherapy
11/2018 - 09/2012
1Hematopoietic Stem Cell Transplantation
04/2008
1Renal Dialysis (Hemodialysis)
08/2003
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
07/2003